- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04993053
Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures (TFNA)
Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures in Patients Over 65 Years of Age
Intramedullary nailing is the standard treatment of trochanteric fractures. Mechanical failure such as cut-out and cut-through are associated with high rates of revision surgery, functional impairment and mortality. Augmentation of the implant have shown encouraging results in reducing the number of mechanical failures. The aim of the study was to evaluate the rate of mechanical failure of the cement augmented screws of TFNA nails.
A descriptive, retrospective, multi-operator, single-centre study was performed at our level 1 trauma centre. Patients were included if they were > 65 years of age, presented with a trochanteric fracture treated with an augmented TFNA nail. The primary outcome was fixation failure rate (cut-out or cut-through) at 3 and 6 postoperative months. Secondary endpoints were intraoperative data, clinical scores, and radiographic analysis.
Studieoversikt
Status
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Brest, Frankrike, 29609
- CHU de Brest
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- > 65 years of age
- a trochanteric fracture that occurred through a low-energy mechanism
- an augmented TFNA nail
Exclusion Criteria:
- pathological fracture
- open fracture
- hips with pre-existing deformities other than osteoarthritis
- a history of hip surgery
- an insufficient quantity of injected cement (< 3 mL).
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Fixation failure rate (cut-out or cut-through)
Tidsramme: change at 3 and 6 postoperative months
|
On X rays
|
change at 3 and 6 postoperative months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Visual Analogue Scale score
Tidsramme: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 10, higher scores mean a worse outcome.
|
at 3 and 6 postoperative months
|
analysis evaluating quality of reduction
Tidsramme: once
|
On X rays
|
once
|
Augmentation volume
Tidsramme: once
|
once
|
|
length of surgery
Tidsramme: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
|
radiation exposure
Tidsramme: once
|
once
|
|
duration of hospitalisation
Tidsramme: once
|
once
|
|
Intraoperative adverse events
Tidsramme: once
|
once
|
|
EuroQoL 5-Dimensions score
Tidsramme: change at 3 and 6 postoperative months
|
the minimum is 5 and maximum 15, higher scores mean a worse outcome.
|
change at 3 and 6 postoperative months
|
Parker Mobility Score
Tidsramme: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 9, higher scores mean a better outcome.
|
at 3 and 6 postoperative months
|
Harris Hip Score
Tidsramme: at 3 and 6 postoperative months
|
the minimum is 0 and maximum 100, higher scores mean a betteroutcome.
|
at 3 and 6 postoperative months
|
the tip-apex distance
Tidsramme: once
|
On X rays
|
once
|
TFNA screw position
Tidsramme: once
|
On X rays
|
once
|
distribution of cement on either side of the cervicocephalic screw
Tidsramme: once
|
On X rays
|
once
|
postoperative complications
Tidsramme: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
|
the need for revision surgery
Tidsramme: at 3 and 6 postoperative months
|
at 3 and 6 postoperative months
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TFNA - 29BRC21.0076
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .